FDA approval of palovarotene - SOHONOS

directory of Chem Help ASAP videos: www.chemhelpasap.com/youtube/
channel email: [e-mail]
This video describes the approval of palovarotene (SOHONOS), a retinoic acid receptor gamma agonist for the treatment of heterotopic ossifications and fibrodysplasia ossificans progressiva. Palovarotene was approved by the U.S. FDA on August 16, 2023. The sponsor of the NDA was Ipsen Biotherapeutics. Efficacy, ADME/PK, and key safety risks of palovarotene are discussed.
This video was created for academic purposes. The creator of the video has no financial stake in Ipsen or relationship with the FDA.

[@samahabuomar1050]

Thank you ! this was very helpful :)

[@ChemHelpASAP]

You are welcome. Thanks for watching.